NCT02582047View on ClinicalTrials.gov

Influenza Vaccine and Pneumococcal Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

January 31, 2013

Conditions
Influenza, HumanPneumococcal Infections
Interventions
BIOLOGICAL

Influenza vaccination with PPV23

GCflu and Pneumovax-23

BIOLOGICAL

Influenza vaccination with PCV13

GCflu and Prevenar-13

Trial Locations (2)

15355

Korea University Ansan Hospital, Ansan

07441

Hallym University Gangnam Sacred Hospital, Seoul

All Listed Sponsors
lead

Korea University Guro Hospital

OTHER

NCT02582047 - Influenza Vaccine and Pneumococcal Vaccine | Biotech Hunter | Biotech Hunter